Helse Sør-øst RHF
**Researcher in CRISPR gene therapy group**:
Offentlig forvaltning
Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway, and has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.
**About the laboratory**
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has nationwide responsibility for several national and multi-regional assignments and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all med...